Journavx, a new non-opioid pain medication, offers a safer alternative for managing acute pain while reducing the risk of ...

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

Experts discuss the current research on the use of digital therapeutics for managing chronic pain in rheumatic disease.

New research from McGill University reveals that listening to music at your own rhythm can significantly reduce pain.

The opioid epidemic continues to affect hundreds of thousands of people, but there may be hope for the future with a new, non ...

12 Simple Decor Choices That Instantly Make Your Home Look More Expensive Near-Earth asteroid Bennu could hit Earth in 157 ...

Mumbai: The Vegetarian Society will hold its bi-monthly talk on Thursday, February 13, at Samrat Restaurant, Churchgate ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

Librela (bedinvetmab injection) is a monthly injectable monoclonal antibody, for which real-world drug experience data has ...

While New Orleans prepares for the excitement of the big game, it’s important to remember that sports injuries aren’t limited to the professionals. High school athletes, weekend warriors, and generall ...

Understanding the link between weight and arthritis pain could be key to finding relief. Learn how small changes in lifestyle can make a big difference.